|News & Media|
|Dean J. Mitchell|
|President & Chief Executive Officer
Mr. Mitchell is
the President & Chief Executive Officer at Lux Biosciences, Inc. Mr.
Mitchell is the former President, Chief Executive Officer and Director
of Alpharma Inc., a public human and animal specialty pharmaceutical
company, which was acquired by King Pharmaceuticals in December 2008.
Prior to Alpharma, Mr. Mitchell was President and CEO of Guilford
Pharmaceuticals, a publicly traded specialty pharmaceutical company that
was acquired by MGI Pharmaceuticals in 2005. Before Guilford, Mr.
Mitchell was at Bristol-Myers Squibb, where he was President,
International and President, US Primary Care. Prior to BMS, Mr. Mitchell
spent 14 years at GlaxoSmithKline, most recently as Senior Vice
President, Clinical Development and Product Strategy. Mr. Mitchell
earned his B.Sc. in Applied Biology from Coventry University in the
United Kingdom and his M.B.A. from City University Business School,
London, UK. He is also a non-executive Board member of ISTA
Pharmaceutics, Intrexon and Talecris Biotherapeutics.
© 2012 Lux Biosciences, Inc. All rights reserved. Web Terms